ClinicalTrials.Veeva

Menu

LEONIDaS Caregivers Study

University of Oxford logo

University of Oxford

Status

Withdrawn

Conditions

Depression
Anxiety
Dravet Syndrome

Treatments

Other: Multiple

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT05140122
R76178/RE001

Details and patient eligibility

About

Dravet syndrome is a rare form of severe epilepsy that begins in the first year of life and is associated with frequent and/or prolonged seizures. Individuals with Dravet Syndrome often experience a range of comorbidities, including behavioral and developmental delays, movement and balance issues, sleep difficulties, chronic infections, and growth and nutritional issues. Patients with Dravet syndrome are at high risk of death due to SUDEP (Sudden Unexpected Death in Epilepsy), prolonged seizures, seizure-related accidents, and infections.

Due to the severity of this condition, parents of children with Dravet syndrome are typically highly involved in their child's 24-hour care and this has a considerable impact on family life. Recent studies have highlighted the profound impact that such caregiving has on physical health, mental health, social function and financial resources. In particular, caregivers report high levels of stress and anxiety, fatigue, depression and social isolation. However, there is currently a lack of effective interventions to reduce the negative impact of caregiving on caregivers.

The aim of this study is to prospectively study carers of individuals with Dravet syndrome to identify pharmacological and psychological factors that are associated with increased or decreased vulnerability to stress, depression and anxiety. Using a naturalistic, observational design the investigators will assess a cohort of Dravet Syndrome carers every six months for 3 years in order to further characterise trajectories of caregiver burden and the factors that influence this, including factors related to the person with Dravet syndrome (e.g. age, seizure frequency/severity, treatment/medications, comorbidities) and factors related to the carer and family environment (e.g. social engagement/isolation, fatigue, finances, relationships). The investigators will use both standardized questionnaires and a neurocognitive task (Facial Expression Recognition Task) to assess vulnerability to anxiety and depression. The study will be conducted online.

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Willing and able to give informed consent for participation in the study
  • Aged 18 years or above
  • Primary caregiver of an individual with a medical history supporting a clinical diagnosis of Dravet syndrome
  • Able to access the internet

Exclusion criteria

  • Inability to provide informed written consent
  • Another caregiver of the same individual with Dravet is already enrolled in the study

Trial design

0 participants in 1 patient group

Primary caregivers of individuals with Dravet Syndrome
Treatment:
Other: Multiple
Other: Multiple

Trial contacts and locations

0

Loading...

Central trial contact

Amy Gillespie, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems